Octaplex 500 IU & 1000 IU Injection – Uses, Benefits, Side Effects and Product Details
Description
Octaplex 500 IU and 1000 IU Injection is a human prothrombin complex concentrate used to help restore blood clotting factor levels in specific medical conditions. It contains human coagulation factors II, VII, IX and X, along with proteins C and S. These proteins play important roles in the body's blood-clotting process.
Octaplex is supplied as a powder with a solvent for preparing an intravenous infusion. The 500 IU presentation is supplied with 20 mL of solvent, while the 1000 IU presentation is supplied with 40 mL. It is a prescription-only medicine administered by qualified healthcare professionals under appropriate medical supervision.
Cordium Pharmaceuticals Pvt Ltd provides pharmaceutical product information for healthcare professionals, hospitals, pharmaceutical distributors and international procurement enquiries, subject to applicable supply and regulatory requirements.
Octaplex Injection Strengths and Composition
Octaplex 500 IU Injection: Contains 500 IU of human coagulation factor IX activity per vial.
Octaplex 1000 IU Injection: Contains 1000 IU of human coagulation factor IX activity per vial.
Both presentations contain a combination of vitamin K-dependent coagulation factors and proteins C and S. Availability, approved product information and packaging may vary by destination market.
Uses and Benefits of Octaplex Injection
Octaplex is used when rapid replacement of certain blood-clotting factors is medically necessary. Its principal approved uses include:
1. Reversal of vitamin K antagonist effects: It may be used to treat bleeding or prepare a patient for surgery when rapid correction of coagulation factor deficiency caused by vitamin K antagonist medicines, such as warfarin, is required.
2. Management of specific bleeding conditions: By replacing several coagulation factors, Octaplex helps restore the body's ability to form blood clots when these factors are deficient.
3. Selected inherited coagulation factor deficiencies: It may be used in certain congenital deficiencies of factors II or X when an appropriate specific coagulation factor product is unavailable.
4. Perioperative bleeding management: Under specialist supervision, it may help reduce bleeding risk around surgical procedures in patients with qualifying coagulation factor deficiencies.
Treatment decisions depend on the patient's condition, laboratory results, bleeding severity and the applicable prescribing information.
Side Effects of Octaplex Injection
Like other plasma-derived medicines, Octaplex can cause adverse reactions. Reported effects include:
Blood clots (thrombosis): A potentially serious complication, particularly in patients with existing risk factors.
Allergic reactions: Rash, hives, breathing difficulty or severe hypersensitivity.
Cardiovascular effects: Rapid heartbeat, low blood pressure or circulatory collapse.
Other reactions: Nausea, chills, tremor, injection-site burning and changes in liver function tests.
Heparin-related thrombocytopenia: A potentially serious reduction in platelet count.
Seek immediate medical attention for breathing difficulty, facial swelling, chest pain, sudden weakness or other signs of a severe reaction or blood clot. Healthcare professionals should assess clotting and platelet-related risks before administration.
Frequently Asked Questions (FAQs)
1. What is Octaplex 500 IU Injection used for?
It is used to treat certain coagulation factor deficiencies associated with bleeding or to prepare patients for procedures when rapid correction is required.
2. What is the difference between Octaplex 500 IU and 1000 IU?
The principal difference is the total factor IX activity per vial: 500 IU versus 1000 IU. The appropriate presentation depends on the prescribed dose and clinical circumstances.
3. How is Octaplex administered?
It is reconstituted according to the approved instructions and administered intravenously by a qualified healthcare professional. It must not be self-administered.
4. Can Octaplex cause blood clots?
Yes. Thromboembolic events are a recognised risk. Medical assessment and monitoring are essential, particularly for patients with risk factors.
5. How can international buyers enquire about Octaplex?
Hospitals, licensed pharmaceutical distributors and eligible importers may contact Cordium Pharmaceuticals Pvt Ltd to enquire about product availability, documentation, packaging and export requirements. Supply is subject to local registration, import authorisation and applicable regulations.
Contact Cordium Pharmaceuticals Pvt Ltd
For enquiries regarding Octaplex 500 IU and 1000 IU Injection, contact Cordium Pharmaceuticals Pvt Ltd for product information and applicable pharmaceutical supply requirements. International orders are subject to destination-country regulations and verification of the required authorisations.







